• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析患者中万古霉素的药代动力学
Antimicrob Agents Chemother. 1984 May;25(5):603-6. doi: 10.1128/AAC.25.5.603.
2
Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis.4例持续性非卧床腹膜透析患者中万古霉素的腹膜转运情况
Nephron. 1982;31(1):37-9. doi: 10.1159/000182611.
3
Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析期间腹腔内和静脉注射万古霉素药代动力学的比较研究
Antimicrob Agents Chemother. 1987 Feb;31(2):173-7. doi: 10.1128/AAC.31.2.173.
4
Pharmacokinetics of single dose intravenous vancomycin in CAPD peritonitis.持续性非卧床腹膜透析相关性腹膜炎患者单次静脉注射万古霉素的药代动力学
J Antimicrob Chemother. 1987 Mar;19(3):351-7. doi: 10.1093/jac/19.3.351.
5
Vancomycin disposition during continuous ambulatory peritoneal dialysis: a pharmacokinetic analysis of peritoneal drug transport.持续性非卧床腹膜透析期间万古霉素的处置:腹膜药物转运的药代动力学分析
Antimicrob Agents Chemother. 1985 Apr;27(4):578-82. doi: 10.1128/AAC.27.4.578.
6
Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis.慢性间歇性腹膜透析期间万古霉素的腹膜清除率及全身清除率
Clin Nephrol. 1979 Mar;11(3):129-32.
7
Vancomycin pharmacokinetics in patients undergoing chronic intermittent peritoneal dialysis.慢性间歇性腹膜透析患者的万古霉素药代动力学
Int J Clin Pharmacol Ther Toxicol. 1982 Dec;20(12):559-63.
8
Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析中腹透液中万古霉素的清除及腹腔内万古霉素的平衡
Clin Pharmacokinet. 1990 Jun;18(6):485-90. doi: 10.2165/00003088-199018060-00005.
9
Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis.头孢唑肟在持续非卧床腹膜透析患者中的药代动力学
Antimicrob Agents Chemother. 1983 Aug;24(2):237-9. doi: 10.1128/AAC.24.2.237.
10
[Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].[腹腔内给药后持续非卧床腹膜透析(CAPD)慢性肾衰竭患者万古霉素的药代动力学]
Pathol Biol (Paris). 1985 Jun;33(5 Pt 2):542-4.

引用本文的文献

1
Two Innovative Approaches to Optimize Vancomycin Dosing Using Estimated AUC after First Dose: Validation Using Data Generated from Population PK Model Coupled with Monte-Carlo Simulation and Comparison with the First-Order PK Equation Approach.两种使用首剂后估算曲线下面积优化万古霉素给药剂量的创新方法:利用群体药代动力学模型结合蒙特卡洛模拟生成的数据进行验证,并与一级药代动力学方程方法进行比较。
Pharmaceutics. 2022 May 7;14(5):1004. doi: 10.3390/pharmaceutics14051004.
2
Vancomycin Intoxication and Cefepime-induced Encephalopathy Treated by Abdominal Drainage of Massive Ascites in Addition to Online Hemodiafiltration.在在线血液透析滤过的基础上,通过腹腔引流大量腹水治疗万古霉素中毒和头孢吡肟诱导的脑病。
Intern Med. 2021 Jun 1;60(11):1737-1742. doi: 10.2169/internalmedicine.6233-20. Epub 2021 Jan 8.
3
Vancomycin in peritoneal dialysis: Clinical pharmacology considerations in therapy.万古霉素在腹膜透析中的应用:治疗中的临床药理学考虑。
Perit Dial Int. 2020 Jul;40(4):384-393. doi: 10.1177/0896860819889774. Epub 2020 Feb 17.
4
Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique.采用贝叶斯预测技术测定肥胖对万古霉素药代动力学参数的影响。
Antimicrob Agents Chemother. 1993 Mar;37(3):436-40. doi: 10.1128/AAC.37.3.436.
5
Vancomycin disposition during continuous ambulatory peritoneal dialysis: a pharmacokinetic analysis of peritoneal drug transport.持续性非卧床腹膜透析期间万古霉素的处置:腹膜药物转运的药代动力学分析
Antimicrob Agents Chemother. 1985 Apr;27(4):578-82. doi: 10.1128/AAC.27.4.578.
6
Toxicologic and pharmacokinetic evaluation of a case of vancomycin intoxication during continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析期间万古霉素中毒1例的毒理学和药代动力学评估
Pharm Weekbl Sci. 1986 Dec 12;8(6):293-7. doi: 10.1007/BF02280053.
7
Effect of orally administered activated charcoal on vancomycin clearance.口服活性炭对万古霉素清除率的影响。
Antimicrob Agents Chemother. 1987 May;31(5):720-2. doi: 10.1128/AAC.31.5.720.
8
Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析期间腹腔内和静脉注射万古霉素药代动力学的比较研究
Antimicrob Agents Chemother. 1987 Feb;31(2):173-7. doi: 10.1128/AAC.31.2.173.
9
Clinical pharmacokinetics of vancomycin.万古霉素的临床药代动力学
Clin Pharmacokinet. 1986 Jul-Aug;11(4):257-82. doi: 10.2165/00003088-198611040-00001.
10
Vancomycin pharmacokinetics in patients with various degrees of renal function.不同肾功能程度患者的万古霉素药代动力学
Antimicrob Agents Chemother. 1988 Jun;32(6):848-52. doi: 10.1128/AAC.32.6.848.

本文引用的文献

1
Single-dose kinetics of intravenous vancomycin.静脉注射万古霉素的单剂量动力学
J Clin Pharmacol. 1980 Apr;20(4):197-201. doi: 10.1002/j.1552-4604.1980.tb01696.x.
2
Vancomycin pharmacokinetics in patients undergoing chronic intermittent peritoneal dialysis.慢性间歇性腹膜透析患者的万古霉素药代动力学
Int J Clin Pharmacol Ther Toxicol. 1982 Dec;20(12):559-63.
3
Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis.4例持续性非卧床腹膜透析患者中万古霉素的腹膜转运情况
Nephron. 1982;31(1):37-9. doi: 10.1159/000182611.
4
Vancomycin pharmacokinetics in normal and morbidly obese subjects.正常和病态肥胖受试者的万古霉素药代动力学。
Antimicrob Agents Chemother. 1982 Apr;21(4):575-80. doi: 10.1128/AAC.21.4.575.
5
Vancomycin.万古霉素
Med Clin North Am. 1982 Jan;66(1):175-181. doi: 10.1016/s0025-7125(16)31451-1.
6
Efficacy of intravenous vancomycin in the treatment of gram-positive peritonitis in long-term peritoneal dialysis.静脉注射万古霉素治疗长期腹膜透析患者革兰氏阳性腹膜炎的疗效
Am J Med. 1983 Aug;75(2):345-8. doi: 10.1016/0002-9343(83)91215-9.
7
Vancomycin pharmacokinetics in patients with peritonitis on peritoneal dialysis.接受腹膜透析的腹膜炎患者的万古霉素药代动力学
Antimicrob Agents Chemother. 1983 May;23(5):710-4. doi: 10.1128/AAC.23.5.710.
8
Vancomycin.万古霉素
Mayo Clin Proc. 1983 Feb;58(2):88-91.
9
Vancomycin kinetics during continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析期间的万古霉素动力学
Clin Pharmacol Ther. 1983 Nov;34(5):631-7. doi: 10.1038/clpt.1983.225.
10
Clinical usefulness of vancomycin.万古霉素的临床效用。
Clin Pharm. 1983 Sep-Oct;2(5):417-24.

持续非卧床腹膜透析患者中万古霉素的药代动力学

Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis.

作者信息

Blevins R D, Halstenson C E, Salem N G, Matzke G R

出版信息

Antimicrob Agents Chemother. 1984 May;25(5):603-6. doi: 10.1128/AAC.25.5.603.

DOI:10.1128/AAC.25.5.603
PMID:6732227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC185596/
Abstract

The pharmacokinetics of vancomycin were studied in four patients on continuous ambulatory peritoneal dialysis. After a single intravenous infusion of 10 mg/kg of total body weight, multiple blood, urine, and dialysate samples were collected during a 72-h evaluation period. The steady-state volume of distribution was 0.73 +/- 0.07 (mean +/- standard deviation) liters/kg with a beta half-life of 90.2 +/- 24.2 h. The continuous ambulatory peritoneal dialysis clearance of vancomycin was 1.35 +/- 0.35 ml/min, and the serum clearance was 6.4 +/- 1.1 ml/min. Peritoneal dialysate concentrations of vancomycin were rapidly attained after the intravenous infusion and averaged 2.2 +/- 0.7 mg/liter throughout the 72-h observation period. A loading dose of 23 mg/kg followed by a maintenance dose of 17 mg/kg every 7 days should attain and maintain therapeutic serum and dialysate concentrations. More frequent dosing may be necessary for less susceptible organisms.

摘要

对4例持续性非卧床腹膜透析患者的万古霉素药代动力学进行了研究。在单次静脉输注10mg/kg总体重后,在72小时的评估期内采集了多个血液、尿液和透析液样本。稳态分布容积为0.73±0.07(均值±标准差)升/千克,β半衰期为90.2±24.2小时。万古霉素的持续性非卧床腹膜透析清除率为1.35±0.35毫升/分钟,血清清除率为6.4±1.1毫升/分钟。静脉输注后,腹膜透析液中万古霉素浓度迅速达到,在72小时观察期内平均为2.2±0.7毫克/升。负荷剂量23mg/kg,随后每7天维持剂量17mg/kg,应能达到并维持治疗性血清和透析液浓度。对于敏感性较低的微生物,可能需要更频繁给药。